Research & Development

2013彩票充20送202014080彩票排三杀码2013彩票书籍下载新时代中国空降兵!李振波:41 年初心不改


  公孫弘居住的二樓上依舊亮著燈火,自從他住到雲氏之後,每日里不到子時是不會滅燈的。   雲瑯以為,只要始皇陵沒有被皇帝發現,看看別的沒有什麼大不了的。2013彩票充20送20   阿嬌並未下軟轎,只是探出頭仔細的看了一眼全身被七八個燈籠照的發亮的宋喬,滿意的點點頭,就賞賜了一盒子亂七八糟的好東西,就有宦官開始喝道,軟轎轉了一個彎之後就揚長而去。2014080彩票排三杀码   甦稚的話讓雲瑯這個後世人都感到尷尬,只好舉手投降道︰“好,好,你做主就好,只是聘禮該交給誰?”   “用富貴人家的錢來補償百姓?”2013彩票书籍下载   “薄薄,薄薄!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo